» Articles » PMID: 37112687

Surveillance of Influenza and Other Airborne Transmission Viruses During the 2021/2022 Season in Hospitalized Subjects in Tuscany, Italy

Overview
Date 2023 Apr 28
PMID 37112687
Authors
Affiliations
Soon will be listed here.
Abstract

Winter in the northern hemisphere is characterized by the circulation of influenza viruses, which cause seasonal epidemics, generally from October to April. Each influenza season has its own pattern, which differs from one year to the next in terms of the first influenza case notification, the period of highest incidence, and the predominant influenza virus subtypes. After the total absence of influenza viruses in the 2020/2021 season, cases of influenza were again recorded in the 2021/2022 season, although they remained below the seasonal average. Moreover, the co-circulation of the influenza virus and the SARS-CoV-2 pandemic virus was also reported. In the context of the DRIVE study, oropharyngeal swabs were collected from 129 Tuscan adults hospitalized for severe acute respiratory infection (SARI) and analyzed by means of real-time polymerase chain reaction (RT-PCR) for SARS-CoV-2 and 21 different airborne pathogens, including influenza viruses. In total, 55 subjects tested positive for COVID-19, 9 tested positive for influenza, and 3 tested positive for both SARS-CoV-2 and the A/H3N2 influenza virus. The co-circulation of different viruses in the population requires strengthened surveillance that is no longer restricted to the winter months. Indeed, constant, year-long monitoring of the trends of these viruses is needed, especially in at-risk groups and elderly people.

Citing Articles

SARS-CoV-2 and influenza virus coinfections in the Tuscan population during the 2021/2022 influenza season.

Milano G, Marchi S, Vicenti I, Biba C, Fiaschi L, Trombetta C J Prev Med Hyg. 2024; 65(1):E11-E16.

PMID: 38706768 PMC: 11066830. DOI: 10.15167/2421-4248/jpmh2024.65.1.3179.


Prevalence of Respiratory Viral Infections in Deceased Persons during the COVID-19 Pandemic Season 2021-2022: A Population-Based Observational Study.

Trobajo-Sanmartin C, Navascues A, Fernandez-Huerta M, Martinez-Baz I, Casado I, Ezpeleta C Viruses. 2024; 16(4).

PMID: 38675876 PMC: 11053769. DOI: 10.3390/v16040533.


Epidemiology and burden of respiratory syncytial virus in Italian adults: A systematic review and meta-analysis.

Domnich A, Calabro G PLoS One. 2024; 19(3):e0297608.

PMID: 38442123 PMC: 10914269. DOI: 10.1371/journal.pone.0297608.


Epidemiology and burden of Severe Acute Respiratory Infections (SARI) in the aftermath of COVID-19 pandemic: A prospective sentinel surveillance study in a Tunisian Medical ICU, 2022/2023.

Boussarsar M, Ennouri E, Habbachi N, Bouguezzi N, Meddeb K, Gallas S PLoS One. 2023; 18(12):e0294960.

PMID: 38100529 PMC: 10723666. DOI: 10.1371/journal.pone.0294960.

References
1.
Hasoksuz M, Kilic S, Sarac F . Coronaviruses and SARS-COV-2. Turk J Med Sci. 2020; 50(SI-1):549-556. PMC: 7195990. DOI: 10.3906/sag-2004-127. View

2.
Domnich A, Orsi A, Trombetta C, Guarona G, Panatto D, Icardi G . COVID-19 and Seasonal Influenza Vaccination: Cross-Protection, Co-Administration, Combination Vaccines, and Hesitancy. Pharmaceuticals (Basel). 2022; 15(3). PMC: 8952219. DOI: 10.3390/ph15030322. View

3.
Izikson R, Brune D, Bolduc J, Bourron P, Fournier M, Mallett Moore T . Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study. Lancet Respir Med. 2022; 10(4):392-402. PMC: 8803382. DOI: 10.1016/S2213-2600(21)00557-9. View

4.
Olsen S, Winn A, Budd A, Prill M, Steel J, Midgley C . Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic - United States, 2020-2021. MMWR Morb Mortal Wkly Rep. 2021; 70(29):1013-1019. PMC: 8297694. DOI: 10.15585/mmwr.mm7029a1. View

5.
Petrarca L, Nenna R, Frassanito A, Pierangeli A, Di Mattia G, Scagnolari C . Human bocavirus in children hospitalized for acute respiratory tract infection in Rome. World J Pediatr. 2019; 16(3):293-298. PMC: 7091143. DOI: 10.1007/s12519-019-00324-5. View